About Epinomics
Epinomics is a Healthcare company based in San Francisco (United States) founded in 2013, and was acquired by 10X Genomics in August 2018. Epigenomics research and development services for DNA sequencing are provided. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its competitors include Helix, Benchling and Genuity Science; 3 of its 3 listed competitors have raised funding.
Company details
Epinomics was founded in 2013 and is based in San Francisco, United States. Operations focus on the epigenomics sector, where research and development services for DNA sequencing are offered to biotech and pharmaceutical companies. A bioinformatics tool is developed to facilitate personalized medicine via scientific research, data analytics, and clinical applications. Assistance is provided in identifying clinical biomarkers and progressing therapeutics development.
- Headquarters San Francisco, United States
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website epinomics.co
- Social X Facebook
- Acquired by 10X Genomics (Aug 2018)
- Investors
- Acquired by10X Genomics
(Aug 2018)
Investors in Epinomics
Epinomics has secured backing from 1 investor. Prominent investors backing the company include 10X Genomics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Instrument systems for genomic research and sequencing libraries are developed. | 2012 | 10xgenomics.com | Pleasanton, United States |
Investor details for Epinomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Epinomics
2 dated milestones of Epinomics across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Epinomics is founded.
- Exit Acquired by 10X Genomics.
Competitors of Epinomics
Epinomics has 3 listed competitors in our database, 3 of them funded. They include Helix, Benchling and Genuity Science.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helix.com | 2015 | San Francisco, United States | $435M | Genomic database for clinical research is provided. | ||
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. | |
| genuitysci.com | 2013 | Boston, United States | $515M | AI-based omics data analysis solutions are provided to researchers. |
Detailed competitors of Epinomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Epinomics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Epinomics
Complete news archive for Epinomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epinomics
Epinomics was founded in 2013.
Epinomics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Epinomics was founded in 2013 and is based in San Francisco, United States. Operations focus on the epigenomics sector, where research and development services for DNA sequencing are offered to biotech and pharmaceutical companies. A bioinformatics tool is developed to facilitate personalized medicine via scientific research, data analytics, and clinical applications. Assistance is provided in identifying clinical biomarkers and progressing therapeutics development.
Epinomics's top competitors include Helix, Benchling and Genuity Science.
Epinomics has 1 investor. Key investors include 10X Genomics.
Yes. Epinomics was acquired by 10X Genomics in August 2018.

